HomeGeneticsGeneDCX gene
Back to Gene
DCX gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

DCX gene

The DCX gene provides instructions for producing doublecortin, a protein critical for the proper migration of neurons during brain development.

Normal Function

The DCX gene provides instructions for producing a protein called doublecortin. This protein is involved in the movement of nerve cells (neurons) to their proper locations in the developing brain, a process called neuronal migration. Doublecortin attaches (binds) to microtubules, which are rigid, hollow fibers that make up the cell's structural framework (the cytoskeleton). The binding of doublecortin promotes the stability of microtubules. Microtubules help propel neurons by forming scaffolding within the cell that elongates in a specific direction, altering the cytoskeleton and moving the neuron.

Health Conditions Related to Genetic Changes

Isolated lissencephaly sequence

More than 70 mutations in the DCX gene have been found to cause isolated lissencephaly sequence (ILS). This condition is characterized by abnormal brain development that results in the brain having a smooth surface (lissencephaly) instead of its normal folds and grooves. Individuals with ILS have severe neurological problems, including severe intellectual disability and recurrent seizures (epilepsy) that begin in infancy. Most of the DCX gene mutations that cause ILS change a single protein building block (amino acid) in doublecortin and usually result in a protein with little or no function. A lack of normal doublecortin affects the stability and organization of microtubules, impairing their ability to move neurons.

Subcortical band heterotopia

More than 100 mutations in the DCX gene have been found to cause subcortical band heterotopia. This condition causes abnormal brain development that is less severe than ILS. In people with subcortical band heterotopia, some neurons that should be part of a certain region of the brain do not reach their destination. The neurons stop their migration process in areas of the brain where they are not supposed to be and form band-like clusters of tissue.

Mutations in the DCX gene are the most common cause of subcortical band heterotopia. Most of these mutations change single amino acids in the doublecortin protein, impairing the protein's function or altering its structure or stability. As a result, the doublecortin protein has a reduced ability to bind to microtubules, impairing their ability to move neurons during neuronal migration.

Females with a mutation in one copy of the DCX gene in each cell usually develop subcortical band heterotopia, while males with one DCX gene mutation generally have ILS. Most males with subcortical band heterotopia have a DCX gene mutation in only some of the body's cells, a situation known as mosaicism.

Other Names for This Gene

  • DBCN
  • DC
  • DCX_HUMAN
  • doublecortex
  • doublecortex; lissencephaly, X-linked (doublecortin)
  • lissencephalin-X
  • LISX
  • XLIS

Frequently Asked Questions

The DCX gene is located on the X chromosome. Because males have only one X chromosome, a loss-of-function mutation leaves them with no functional doublecortin protein, leading to widespread failure of neuronal migration and classic, severe isolated lissencephaly sequence (smooth brain). In contrast, females have two X chromosomes. Due to random X-chromosome inactivation, roughly half of their developing neurons produce normal doublecortin while the other half lack it. This mosaic pattern allows many neurons to reach the cortex normally while others arrest prematurely in the white matter, creating a secondary band of gray matter known as subcortical band heterotopia or double cortex syndrome.
If the mother is found to carry a DCX mutation on targeted blood testing, there is a 50 percent chance of transmitting the altered gene in each pregnancy, with male fetuses at risk for lissencephaly and female fetuses at risk for band heterotopia. However, in roughly 10 percent of families where a mother tests negative on peripheral blood, the mutation is present as germline or somatic mosaicism. Because maternal germline mosaicism cannot be excluded through standard blood work, the recurrence risk for clinically unaffected parents remains estimated at 5 to 10 percent, warranting prenatal diagnostic counseling for future pregnancies.
Yes, but timing and imaging modality are critical. Routine early obstetric ultrasound may appear entirely normal because cerebral gyri and sulci do not fully develop until late in the second trimester. Lissencephaly and band heterotopia are best evaluated via dedicated fetal brain MRI performed between 24 and 32 weeks of gestation, when the abnormal laminar architecture of the cortex becomes evident. Diagnostic confirmation requires molecular genetic testing (such as a multi-gene neurodevelopmental panel or prenatal exome sequencing) obtained via amniocentesis or chorionic villus sampling.
Epilepsy associated with DCX mutations is frequently drug-resistant and can present in infancy as infantile spasms before evolving into refractory focal or generalized seizures. First-line therapies typically involve broad-spectrum antiseizure medications (such as levetiracetam, lamotrigine, or valproate), with hormonal therapy (ACTH) or vigabatrin used if infantile spasms occur. Because resective epilepsy surgery is rarely an option due to the diffuse nature of the cortical malformation, neuromodulatory therapies like vagus nerve stimulation (VNS) or dietary approaches such as the ketogenic diet are often incorporated into care.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss